---
title: "Phase 3 Trial of Chemoradiotherapy With Temozolomide Plus Nivolumab or Placebo for Newly Diagnosed Glioblastoma With Methylated MGMT Promoter."
date: 2022-05-06
enddate:
---

Published in: *Neuro-oncology*

DOI: [10.1093/neuonc/noac116](https://doi.org/10.1093/neuonc/noac116)

<img src="https://upload.wikimedia.org/wikipedia/commons/thumb/0/0e/Closed_Access_logo_transparent.svg/1200px-Closed_Access_logo_transparent.svg.png" alt="drawing" width="25" align="left"/> &nbsp;&nbsp;&nbsp;This publication is not available in Open Access.


